Under construction – not a live service
Sign in
WithdrawnNo phase

Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer

Reason given: PI not moving forward with study at our institution

Trial details

Who runs it
Wake Forest University Health Sciences
Trial code
NCT06362421
Record updated
31 July 2025
Original description
The purpose of this research study is to determine if saliva and oral swab samples can be used to detect human papillomavirus in patients with cancer. In this study, the methods required to detect human papillomavirus will be developed and tested in samples collected from patients with oropharyngeal squamous cell carcinoma and compared to samples collected from participants without cancer.Read full original descriptionShow less

Proof of Concept Assay Development of Point of Care Saliva Testing for High Risk-HPV Oral Cavity and Pharynx Cancers

The purpose of this research study is to determine if saliva and oral swab samples can be used to detect human papillomavirus in patients with cancer. In this study, the methods required to detect human papillomavirus will be developed and tested in samples collected from patients with oropharyngeal squamous cell carcinoma and compared to samples collected from participants without cancer.

Inclusion: Patients must have histologically confirmed oropharyngeal squamous cell carcinoma without prior treatment. A pathology report should be referenced/available; Patients with p16 positive oropharyngeal squamous cell carcinoma; Age 39 to 59 years; Ability to understand and the willingness to sign an IRB-approved informed consent document directly; Age 39 to 59 years; Ability to understand and the willingness to sign an IRB-approved informed consent document directly.

Exclusion: Patients with current or previous diagnosis with HPV+ infection status for cervical cancer or other cancers; Previous diagnosis of cervical cancer or other cancers; Patients with diagnoses of other cancers; Presence of known active oral infections of viral, fungal, or bacterial etiology except for gingivitis, periodontitis, or periapical abscess. Participants with known gingivitis, periodontitis, or periapical abscess are included.

ClinicalTrials.gov NCT06362421

Under construction, not live – Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer (NCT06362421) – Frontlight Research